Atyr Pharma Inc (LIFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,014 | 430,440 | 377,830 | 377,850 | 144,590 |
| Depreciation Amortization | 925 | 442,100 | 493,190 | 531,550 | 583,890 |
| Other Working Capital | 1,849 | 3,360 | -26,950 | -101,430 | -87,820 |
| Other Operating Activity | -71 | -97,910 | -34,940 | -68,890 | 73,810 |
| Operating Cash Flow | $-17,311 | $777,990 | $809,130 | $739,080 | $714,470 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -644 | -116,250 | -99,290 | -124,810 | -175,580 |
| Net Acquisitions | N/A | -148,990 | -20 | -343,380 | -39,790 |
| Other Investing Activity | 0 | -14,230 | -52,570 | 348,390 | -42,620 |
| Investing Cash Flow | $-644 | $-279,470 | $-151,880 | $-119,800 | $-257,990 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,000 | N/A | N/A | N/A | N/A |
| Debt Issued | 10,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -500 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 77 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 36,160 | -1,082,410 | -627,260 | -407,800 | -242,340 |
| Financing Cash Flow | $50,737 | $-1,082,410 | $-627,260 | $-407,800 | $-242,340 |
| Exchange Rate Effect | N/A | 680 | -4,790 | 5,500 | 46,520 |
| Beginning Cash Position | 3,675 | 838,760 | 813,560 | 596,580 | 335,930 |
| End Cash Position | 36,457 | 255,540 | 838,760 | 813,560 | 596,580 |
| Net Cash Flow | $32,782 | $-583,210 | $25,190 | $216,980 | $260,650 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,311 | 777,990 | 809,130 | 739,080 | 714,470 |
| Capital Expenditure | -644 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -17,955 | 777,990 | 809,130 | 739,080 | 714,470 |